Delivery Order SPE2DB20D3103-SPE2DB24FM4U5
Award Date
1/30/24
Potential Completion Date
1/31/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,563,492,997 units of Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,500.00 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024 with a completion date of January 31, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award is for the delivery of Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,500.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 9, 2024, with a completion date of February 12, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,400.00 fixed-price delivery order is for the supply of 4,564,081,943 units of Doxorubicin Liposome 20mg/10ml 10ml, a specialty pharmaceutical product, with a performance period through March 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up...
This federal contract award is a delivery order (SPE2DB20D3103|SPE2DB24FM4V2) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563493004 - Doxorubicin Liposome 50mg/25ml 25ml. The $1,500.00 firm fixed price award was made by the Defense Logistics Agency (DLA) on January 30, 2024, with a completion date of January 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of 4559936723 - Doxorubicin Liposome 50mg/25ml, 25ml. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 14, 2023. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,467.98 and a completion date of February 15, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
The U.S. government has awarded a Delivery Order contract worth $1,164.26 to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of April 23, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally....
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on June 17, 2024, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
The Defense Logistics Agency (DLA) awarded a $1,691.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564010703 ! DOXIL 20 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as Amerisourcebergen's primary contract vehicle to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...